Roche reveals first data with Carmot-sourced oral GLP-1 drug
Vertex, Orum partner on safer pre-treatment for gene meds
Drug development and compliance: 4 Ways AI is impacting pharma
Huma raises $80m, launches 'Shopify for digital health'
GLP-1 bonanza spurs big investment at CDMO CordenPharma
Artiva announces terms for its second IPO attempt
Novo leads $100m financing for Alzheimer's player Asceneuron
How the pandemic exposed faulty links in the supply chain
NHS on course to use digital tech to diagnose ADHD
Call goes out for simpler clinical trial regulation in UK
Lexeo therapy gives hope to Friedreich's ataxia patients
France warns of penalties if Opella production goes offshore
Sanofi is now in exclusive talks with private equity company Clayton Dubilier & Rice over the sale of a controlling stake in its consumer health business Opella, as the French governmen
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
8th Dermatology Drug Development Summit
Industry’s Destination to Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease